Nazila Shafagati

Also affiliated with Sidney Kimmel Comprehensive Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis”.

Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis

Blood Advances(2022)10.1182/bloodadvances.2022007425

N/A

0.489DataRank · unranked

9 citations

Min Jung Koh, Leora Boussi, Hyun J. Park, Robert Stuver, Paul Bain +4 more

Antibody-Based Therapies for Peripheral T-Cell Lymphoma

Cancers(2024)10.3390/cancers16203489

N/A

0.241DataRank · unranked

4 citations

Suman Paul, Sima Rozati, Cole Sterling, Nazila Shafagati